San Antonio Breast Cancer Symposium 2008
Alternating mammography and MRI every 6 months appears to be the best way to detect cancer in high-risk women, an M.D. Anderson study found. This strategy can identify cancers not found by mammography alone, said Huong Le-Petross, MD, assistant professor, Diagnostic Radiology, who presented a retrospective pilot study at a poster session during the San Antonio Breast Cancer Symposium.
Accuracy of Oncotype DX Confirmed for Patients with Early Stage Breast Cancer Treated with Aromatase Inhibitors
Previous research indicates that dense breast tissue is a risk factor for breast cancer development. Some studies have suggested that women who have highly dense breasts (≥60%-75% dense tissue) were as much as six times more likely to develop carcinoma of the breast than women whose breasts consisted primarily of fatty tissue.
Significant Increased Recurrence Rates Among Breast Cancer Patients with HER2-positive, T1a,bN0M0 Tumors
Meta-analysis Finds Aromatase Inhibitors Decrease Rates of Cancer Recurrence and Death Compared with Tamoxifen
Tolerability and Adherence to Hormonal Therapy Difficult to Asses in Patients with Early Breast Cancer
Adjuvant Therapy with Letrozole Improves Disease-Free Survival for Some Women with Early Stage Breast Cancer
Early Breast Cancer Patients Live Longer on Sequencing Tamoxifen and Anastrozole Versus 5 Years of Tamoxifen